Effectiveness of pharmacist intervention in the management of coronary artery disease after index percutaneous coronary intervention: a single center randomized controlled trial

被引:0
作者
Xu, Nongzhang [1 ,2 ]
Wang, Cuihong [2 ]
Wan, Jianwei [2 ]
Liu, Xiaoqing [2 ]
Li, Zhongdong [1 ]
Chen, Min [2 ]
机构
[1] Fudan Univ, Dept Pharm, Huashan Hosp, Shanghai, Peoples R China
[2] Shanghai Univ Med & Hlth Sci, Dept Pharm, Zhoupu Hosp, Shanghai, Peoples R China
关键词
Coronary artery disease; percutaneous coronary intervention; pharmaceutical care; medication adherence; SECONDARY PREVENTION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; IMPACT;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: This study aimed to explore the effect of pharmacist intervention on medication adherence, risk factor control, 6 months prognosis, and 2 years prognosis in patients with coronary artery disease (CAD) after the index percutaneous coronary intervention (PCI). Methods: From January 2015 to December 2015, 200 CAD patients were treated with PCI at our hospital. The control group was given routine treatment and nursing care. In addition to routine treatment and nursing care, the intervention group was given direct pharmacist intervention including medication program optimization, formulated pharmaceutical care, medication education, health education, and outpatient follow-up. The two groups were followed for two years. Readmission rate, incidence of major adverse cardiac events (MACE), readmission expense, awareness rate of secondary prevention drugs, medication adherence, and emotion management were compared between the two groups at 6 months and 2 years after the index procedure. Risk factors in the two groups at 2 years were compared. Results: At 2 years, the risk factors in the intervention group were significantly improved in comparison with the control group [smoking: 3.1% vs. 12.6%, P = 0.012; normal blood glucose rate: 79.6% vs. 62.1%, P = 0.007; normal blood pressure rate: 74.5% vs. 53.7%, P = 0.003; normal blood lipid rate: 84.7% vs. 57.9%, P < 0.001]. The readmission rate, MACE incidence, and readmission expense in the intervention group were significantly lower than the control group at 6 months and 2 years [47.7% vs. 72.6%, P = 0.001; 17.3% vs. 28.8%, P < 0.001; 7512.5 +/- 10269.6 RMB vs. 22172.6 +/- 24413.2 RMB, P= 0.025]. Conclusion: Pharmacist intervention can effectively improve medication adherence, reduce postoperative risk factors, MACE incidence, medical expenses in patients after the index PCI. These beneficial effects were increasingly more significant along with time.
引用
收藏
页码:7760 / 7765
页数:6
相关论文
共 20 条
[1]  
[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s004, 10.2337/dc35-S011]
[2]  
[Anonymous], 2007, ZHONGHUA XINXUEGUANB
[3]   Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials [J].
Cai, Hongwen ;
Dai, Haibin ;
Hu, Yangmin ;
Yan, Xiaofeng ;
Xu, Huimin .
BMC HEALTH SERVICES RESEARCH, 2013, 13
[4]   Meta-analysis: Secondary prevention programs for patients with coronary artery disease [J].
Clark, AM ;
Harding, L ;
Vandermeer, B ;
McAlister, FA .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (09) :659-672
[5]   Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study [J].
Cordero, Alberto ;
Rodriguez Padial, Luis ;
Batalla, Alberto ;
Lopez Barreiro, Luis ;
Torres Calvo, Francisco ;
Castellano, Jose M. ;
Ruiz, Emilio ;
Bertomeu-Martinez, Vicente .
CARDIOVASCULAR THERAPEUTICS, 2017, 35 (02)
[6]   Controlling surface properties and permeability of polyglycerol network films [J].
Dal Bianco, Andrea ;
Wischke, Christian ;
Zhou, Shuo ;
Lendlein, Andreas .
POLYMERS FOR ADVANCED TECHNOLOGIES, 2017, 28 (10) :1263-1268
[7]   Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials [J].
Farkouh, Michael E. ;
Boden, William E. ;
Bittner, Vera ;
Muratov, Victoria ;
Hartigan, Pamela ;
Ogdie, May ;
Bertolet, Marnie ;
Mathewkutty, Shiny ;
Teo, Koon ;
Maron, David J. ;
Sethi, Sanjum S. ;
Domanski, Michael ;
Frye, Robert L. ;
Fuster, Valentin .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (15) :1607-1615
[8]   2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary [J].
Hillis, L. David ;
Smith, Peter K. ;
Anderson, Jeffrey L. ;
Bittl, John A. ;
Bridges, Charles R. ;
Byrne, John G. ;
Cigarroa, Joaquin E. ;
DiSesa, Verdi J. ;
Hiratzka, Loren F. ;
Hutter, Adolph M., Jr. ;
Jessen, Michael E. ;
Keeley, Ellen C. ;
Lahey, Stephen J. ;
Lange, Richard A. ;
London, Martin J. ;
Mack, Michael J. ;
Patel, Manesh R. ;
Puskas, John D. ;
Sabik, Joseph F. ;
Selnes, Ola ;
Shahian, David M. ;
Trost, Jeffrey C. ;
Winniford, Michael D. ;
Jacobs, Alice K. ;
Anderson, Jeffrey L. ;
Albert, Nancy ;
Creager, Mark A. ;
Ettinger, Steven M. ;
Guyton, Robert A. ;
Halperin, Jonathan L. ;
Hochman, Judith S. ;
Kushner, Frederick G. ;
Ohman, E. Magnus ;
Stevenson, William ;
Yancy, Clyde W. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 143 (01) :4-34
[9]   Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease [J].
Ho, P. Michael ;
Magid, David J. ;
Shetterly, Susan M. ;
Olson, Kari L. ;
Maddox, Thomas M. ;
Peterson, Pamela N. ;
Masoudi, Frederick A. ;
Rumsfeld, John S. .
AMERICAN HEART JOURNAL, 2008, 155 (04) :772-779
[10]   Secondary prevention for patients after a myocardial infarction: summary of updated NICE guidance [J].
Jones, Katie ;
Saxon, Leanne ;
Cunningham, William ;
Adams, Phil .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 347